Mirae Asset Global ETFs Holdings
PRME icon

Mirae Asset Global ETFs Holdings’s Prime Medicine PRME Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$600K Buy
162,338
+39,875
+33% +$132K ﹤0.01% 1905
2026
Q1 		$421K Buy
122,463
+7,403
+6% +$28.2K ﹤0.01% 1970
2025
Q4 		$399K Sell
115,060
-5,363
-4% -$23.9K ﹤0.01% 2000
2025
Q3 		$667K Buy
120,423
+567
+0.5% +$2.3K ﹤0.01% 1722
2025
Q2 		$296K Buy
119,856
+85,938
+253% +$132K ﹤0.01% 2077
2025
Q1 		$67.5K Buy
33,918
+1,419
+4% +$3.62K ﹤0.01% 2777
2024
Q4 		$94.9K Buy
32,499
+1,372
+4% +$4.82K ﹤0.01% 2721
2024
Q3 		$120K Buy
31,127
+11,603
+59% +$53.7K ﹤0.01% 2624
2024
Q2 		$100K Buy
+19,524
New +$118K ﹤0.01% 2560

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PRME Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Prime Medicine (PRME) stake by 33% in Q2 2026, buying an estimated $132K and bringing the position to 162,338 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

Mirae Asset Global ETFs Holdings first reported a position in PRME in Q2 2024 and has held it in 9 quarters since. The position peaked at $667K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 162,338 shares of Prime Medicine worth $600K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 39,875 Prime Medicine shares in Q2 2026, an estimated $132K.
  • Prime Medicine made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1905 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Prime Medicine in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Prime Medicine position peaked at $667K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.